Case Report

Case 1
This was the fourth pregnancy of a 35-year-old, gravida 4, para 2, woman. Amniocentesis was performed at 17 weeks' gestation because of advanced maternal age and a previous child with rea(21q21q) Down syndrome. The woman had experienced one previous abortion. She had a 5-year-old daughter affected with homologous Robertsonian translocation Down syndrome and a 3-year-old normal daughter with a 46,XX karyotype. Polymorphic DNA marker analysis of the affected daughter showed that the rea(21q21q) was isochromosome 21 and was of maternal origin ( Figure  2 ). The karyotype was 46,XX,i(21)(q10). Parental karyotypes derived from blood lymphocytes were normal. Amniocentesis during the current pregnancy revealed recurrent rea(21q21q) Down syndrome. Polymorphic DNA marker analysis showed that the rea(21q21q) was isochromosome 21 and was of maternal origin ( Figure 2 ). The karyotype was 46,XY,i(21)(q10). The pregnancy was subsequently terminated. The karyotype of cord blood lymphocytes was 46,XY,i(21)(q10). Her fifth pregnancy resulted in a normal male baby with a 46,XY karyotype.
Case 2
This was the second pregnancy of a 36-year-old, gravida 2, para 1, woman. Amniocentesis was performed at 16 weeks' gestation because of advanced maternal age and a previous child with rea(21q21q) Down syndrome. She had a 2-year-old daughter affected with rea(21q21q) Down syndrome. Polymorphic DNA marker analysis showed that the rea(21q21q) was isochromosome 21 and was of maternal origin ( Figure 3 ). The karyotype was 46,XX,i(21)(q10). The parental karyotypes derived from blood lymphocytes were normal. 
Case 4
This was the first pregnancy of a 30-year-old, gravida 1, para 0, woman. Amniocentesis was performed at 18 weeks' gestation because of increased nuchal thickness. Amniocentesis revealed rea(21q21q) Down syndrome. The parental karyotypes derived from blood lymphocytes were normal. Polymorphic DNA marker analysis showed that the rea(21q21q) was isochromosome 21 and was of maternal origin. The karyotype was 46,XX,i(21)(q10). The pregnancy was subsequently terminated. The karyotype of cord blood lymphocytes was 46,XX,i(21)(q10).
Case 5
This was the first pregnancy of a 34-year-old, gravida 1, para 0, woman. Amniocentesis was performed at 19 weeks' gestation because of advanced maternal age. Amniocentesis revealed rea(21q21q) Down syndrome. The parental karyotypes derived from blood lymphocytes were normal. Polymorphic DNA marker analysis showed that the rea(21q21q) was isochromosome 21 and was of maternal origin. The karyotype was 46,XX, i(21)(q10). The pregnancy was subsequently terminated.
Case 6
This was the second pregnancy of a 26-year-old, gravida 2, para 1, woman. Amniocentesis was performed at 15 weeks' gestation because of a previous fetus with rea(21q21q) Down syndrome. The fetus of her first pregnancy had rea(21q21q) Down syndrome with a 46,XX,+21, der(21;21)(q10;q10) karyotype, which was diagnosed by amniocentesis 2 years prior to the 
Discussion
Chen et al [2] previously reported a frequency of chromosome aberrations of 2.53% among 166,419 amniocenteses, and about 30% of the detected aneuploidies were Down syndrome. In this report, we found a frequency of 0.019% for rea(21q21q) Down syndrome among patients who underwent amniocentesis. We determined that rea(21q21q) Down syndrome could be associated with advanced maternal age (Cases 1, 2 and 5), a previous child with rea(21q21q) Down syndrome (Cases 1, 2 and 6), an abnormal maternal serum screening result (Case 3) or an abnormal ultrasound finding (Case 4), and that the homologous rearrangement rea(21q21q) Down syndrome could be associated with recurrence. Homologous rearrangement rea(21q21q) Down syndrome includes isochromosome 21 i(21q) Down syndrome and homologous Robertsonian translocation rob(21q21q) Down syndrome. More than 95% of rea(21q21q) Down syndrome cases arise de novo [3] . In isochromosome 21 Down syndrome, i(21q) is derived from a single chromosome 21; whereas in homologous Robertsonian translocation Down syndrome, rob (21q21q) is derived from two different homologous chromosome 21 [3, 4] . Conventional cytogenetic analysis is unable to distinguish between rob(21q21q) and i(21q), and molecular technology using polymorphic DNA markers is required to make this distinction.
The majority of cases with rea(21q21q) Down syndrome reported to date have been of i(21q) Down syndrome [3] [4] [5] [6] . In a meta-analysis of 34 cases of rea (21q21q) Down syndrome based on three reports [3, 5, 6 ], Kovaleva and Shaffer [7] found that 30 cases (88.2%) were i(21q) Down syndrome, and four (11.8%) were rob(21q21q) Down syndrome. The incidence of maternally derived i(21q) has been noted to be similar to that of paternally derived i(21q) [3, 5, 8, 9] . Most cases with i(21q) showed no recombination, consistent with a postzygotic mitotic event [4, 10, 11] , whereas only a few showed recombination consistent with a meiotic event [3, 9] .
All six of the current cases arose de novo. These six cases underwent molecular analysis and demonstrated isochromosome 21, five of which were determined to be of maternal origin. These cases were likely to be the results of mitotic events. The recurrence of rea(21q21q) Down syndrome in Cases 1, 2 and 6 is of interest. Recurrence of rea(21q21q) Down syndrome has been shown to be associated with low-level parental mosaicism or gonadal mosaicism. Kovaleva and Shaffer [7] found that parents of rea(21q21q) Down syndrome offspring more often demonstrated mosaicism. They found a sevenfold increase in the number of mosaic cases in parents of rea(21q21q) Down syndrome offspring compared with parents of non-rea(21q21q) offspring. Kovaleva and Shaffer [7] suggested that extensive parental analysis for mosaicism should be undertaken in cases of recurrent rea(21q21q) Down syndrome. The recurrence rate for de novo rea(21q21q) Down syndrome has been reported to be low. In a study of 112 families with a child with de novo 21q21q translocation Down syndrome, Steinberg et al [12] found that none of the parents had a second child with Down syndrome, and three of 112 sets of parents had low-grade mosaicism for a 21q21q translocation. However, three of the six cases (50%) in our study were associated with recurrence. In the families with recurrent de novo rea(21q21q) Down syndrome, several reports have demonstrated mosaicism for rea(21q21q) in the skin or ovary of one parent but normal karyotypes in the parental blood lymphocytes [13] [14] [15] [16] [17] and very low levels of rea(21q21q) mosaicism in the blood lymphocytes of one parent [18] . Parental cytogenetic studies of tissues, as well as blood, could therefore be helpful for detecting low percentage mosaicism in the parents of families with recurrent Down syndrome. Preimplantation genetic screening using fluorescence in situ hybridization or comparative genomic hybridization for the analysis of chromosomes in preimplantation embryos may provide parents with the chance of starting a pregnancy knowing that the baby will be free of Down syndrome. The recurrence of familial rea(21q21q) Down syndrome in pregnancies of couples in whom one of the partners is a carrier of balanced rea(21q21q) is 100%. In such cases, genetic counseling should include advice to refrain from further pregnancies, the use of artificial insemination with normal donor sperm (in case of a male carrier), or the use of normal donor ova (in case of a female carrier).
